Table 2.
|
EXE (n = 38) |
WI (n = 38) |
EXE vs. WI |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Variables | Pre | Post | Difference ± SD | P a | Pre | Post | Difference ± SD | P a | P b | ES |
FS | 39.00 (1.32) | 48.00 (0.78) | 10.15 ± 6.40 (8.07–12.22) | <0.001b | 41.00 (1.67) | 38.00 (1.50) | −1.41 ± 8.98 (−4.32–1.50) | 0.391 | <0.001a | 1.482 |
FACT-G | 82.00 (2.26) | 91.00 (2.01) | 7.04 ± 11.22 (3.40–10.67) | <0.001b | 83.57 (2.57) | 77.66 (2.46) | −9.50 ± 9.16 (−1.13–8.06) | 0.129 | <0.001a | 1.615 |
FACIT-F | 121.00 (3.09) | 138.00 (2.60) | 17.90 ± 12.12 (12.92–21.44) | <0.001b | 127.66 (3.89) | 115.16 (3.62) | −12.77 ± 15.77 (−11.17–1.41) | 0.097 | 0.034a | 2.181 |
BORG | 7.00 (0.32) | 4.00 (0.23) | −2.95 ± 2.50 (−3.76− −2.14) | <0.001b | — | — | — | — | — | 1.694 |
Wilcoxon test (Pre vs. Post).
Mann–Whitney test (EXE vs. WI).
95% CI, 95% confidence interval; ES, effect size; EXE, exergaming; FACIT-F, Functional Assessment of Chronic Illness Therapy-Fatigue; FACT-G, Functional Assessment of Cancer Therapy-General; FS, fatigue subscale; SD, standard deviation; WI, without intervention.